NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly) AND Breast-ovarian cancer, familial, susceptibility to, 1
- Germline classification:
- Pathogenic (25 submissions)
- Last evaluated:
- Aug 10, 2015
- Review status:
- 3 stars out of maximum of 4 starsreviewed by expert panel
- Somatic classification
of clinical impact: - None
- Review status:
- (0/4) 0 stars out of maximum of 4 starsno assertion criteria provided
- Somatic classification
of oncogenicity: - None
- Review status:
- (0/4) 0 stars out of maximum of 4 starsno assertion criteria provided
- Record status:
- current
- Accession:
- RCV000019229.51
Allele description [Variation Report for NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)]
NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)
- Gene:
- BRCA1:BRCA1 DNA repair associated [Gene - OMIM - HGNC]
- Variant type:
- single nucleotide variant
- Cytogenetic location:
- 17q21.31
- Genomic location:
- Preferred name:
- NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)
- Other names:
- p.C61G:TGT>GGT; NP_009225.1:p.Cys61Gly
- HGVS:
- NC_000017.11:g.43106487A>C
- NG_005905.2:g.111497T>G
- NM_001407571.1:c.-8T>G
- NM_001407581.1:c.181T>G
- NM_001407582.1:c.181T>G
- NM_001407583.1:c.181T>G
- NM_001407585.1:c.181T>G
- NM_001407587.1:c.181T>G
- NM_001407590.1:c.181T>G
- NM_001407591.1:c.181T>G
- NM_001407593.1:c.181T>G
- NM_001407594.1:c.181T>G
- NM_001407596.1:c.181T>G
- NM_001407597.1:c.181T>G
- NM_001407598.1:c.181T>G
- NM_001407602.1:c.181T>G
- NM_001407603.1:c.181T>G
- NM_001407605.1:c.181T>G
- NM_001407610.1:c.181T>G
- NM_001407611.1:c.181T>G
- NM_001407612.1:c.181T>G
- NM_001407613.1:c.181T>G
- NM_001407614.1:c.181T>G
- NM_001407615.1:c.181T>G
- NM_001407616.1:c.181T>G
- NM_001407617.1:c.181T>G
- NM_001407618.1:c.181T>G
- NM_001407619.1:c.181T>G
- NM_001407620.1:c.181T>G
- NM_001407621.1:c.181T>G
- NM_001407622.1:c.181T>G
- NM_001407623.1:c.181T>G
- NM_001407624.1:c.181T>G
- NM_001407625.1:c.181T>G
- NM_001407626.1:c.181T>G
- NM_001407627.1:c.181T>G
- NM_001407628.1:c.181T>G
- NM_001407629.1:c.181T>G
- NM_001407630.1:c.181T>G
- NM_001407631.1:c.181T>G
- NM_001407632.1:c.181T>G
- NM_001407633.1:c.181T>G
- NM_001407634.1:c.181T>G
- NM_001407635.1:c.181T>G
- NM_001407636.1:c.181T>G
- NM_001407637.1:c.181T>G
- NM_001407638.1:c.181T>G
- NM_001407639.1:c.181T>G
- NM_001407640.1:c.181T>G
- NM_001407641.1:c.181T>G
- NM_001407642.1:c.181T>G
- NM_001407644.1:c.181T>G
- NM_001407645.1:c.181T>G
- NM_001407646.1:c.181T>G
- NM_001407647.1:c.181T>G
- NM_001407648.1:c.181T>G
- NM_001407649.1:c.181T>G
- NM_001407652.1:c.181T>G
- NM_001407664.1:c.181T>G
- NM_001407665.1:c.181T>G
- NM_001407666.1:c.181T>G
- NM_001407667.1:c.181T>G
- NM_001407668.1:c.181T>G
- NM_001407669.1:c.181T>G
- NM_001407670.1:c.181T>G
- NM_001407671.1:c.181T>G
- NM_001407672.1:c.181T>G
- NM_001407673.1:c.181T>G
- NM_001407674.1:c.181T>G
- NM_001407675.1:c.181T>G
- NM_001407676.1:c.181T>G
- NM_001407677.1:c.181T>G
- NM_001407678.1:c.181T>G
- NM_001407679.1:c.181T>G
- NM_001407680.1:c.181T>G
- NM_001407681.1:c.181T>G
- NM_001407682.1:c.181T>G
- NM_001407683.1:c.181T>G
- NM_001407684.1:c.181T>G
- NM_001407685.1:c.181T>G
- NM_001407686.1:c.181T>G
- NM_001407687.1:c.181T>G
- NM_001407688.1:c.181T>G
- NM_001407689.1:c.181T>G
- NM_001407690.1:c.181T>G
- NM_001407691.1:c.181T>G
- NM_001407692.1:c.40T>G
- NM_001407694.1:c.40T>G
- NM_001407695.1:c.40T>G
- NM_001407696.1:c.40T>G
- NM_001407697.1:c.40T>G
- NM_001407698.1:c.40T>G
- NM_001407724.1:c.40T>G
- NM_001407725.1:c.40T>G
- NM_001407726.1:c.40T>G
- NM_001407727.1:c.40T>G
- NM_001407728.1:c.40T>G
- NM_001407729.1:c.40T>G
- NM_001407730.1:c.40T>G
- NM_001407731.1:c.40T>G
- NM_001407732.1:c.40T>G
- NM_001407733.1:c.40T>G
- NM_001407734.1:c.40T>G
- NM_001407735.1:c.40T>G
- NM_001407736.1:c.40T>G
- NM_001407737.1:c.40T>G
- NM_001407738.1:c.40T>G
- NM_001407739.1:c.40T>G
- NM_001407740.1:c.40T>G
- NM_001407741.1:c.40T>G
- NM_001407742.1:c.40T>G
- NM_001407743.1:c.40T>G
- NM_001407744.1:c.40T>G
- NM_001407745.1:c.40T>G
- NM_001407746.1:c.40T>G
- NM_001407747.1:c.40T>G
- NM_001407748.1:c.40T>G
- NM_001407749.1:c.40T>G
- NM_001407750.1:c.40T>G
- NM_001407751.1:c.40T>G
- NM_001407752.1:c.40T>G
- NM_001407838.1:c.40T>G
- NM_001407839.1:c.40T>G
- NM_001407841.1:c.40T>G
- NM_001407842.1:c.40T>G
- NM_001407843.1:c.40T>G
- NM_001407844.1:c.40T>G
- NM_001407845.1:c.40T>G
- NM_001407846.1:c.40T>G
- NM_001407847.1:c.40T>G
- NM_001407848.1:c.40T>G
- NM_001407849.1:c.40T>G
- NM_001407850.1:c.40T>G
- NM_001407851.1:c.40T>G
- NM_001407852.1:c.40T>G
- NM_001407853.1:c.-8T>G
- NM_001407854.1:c.181T>G
- NM_001407858.1:c.181T>G
- NM_001407859.1:c.181T>G
- NM_001407860.1:c.181T>G
- NM_001407861.1:c.181T>G
- NM_001407863.1:c.181T>G
- NM_001407879.1:c.-8T>G
- NM_001407881.1:c.-8T>G
- NM_001407882.1:c.-8T>G
- NM_001407884.1:c.-8T>G
- NM_001407885.1:c.-8T>G
- NM_001407886.1:c.-8T>G
- NM_001407887.1:c.-8T>G
- NM_001407889.1:c.-8T>G
- NM_001407894.1:c.-8T>G
- NM_001407895.1:c.-8T>G
- NM_001407896.1:c.-8T>G
- NM_001407897.1:c.-8T>G
- NM_001407898.1:c.-8T>G
- NM_001407899.1:c.-8T>G
- NM_001407900.1:c.-8T>G
- NM_001407902.1:c.-8T>G
- NM_001407904.1:c.-8T>G
- NM_001407906.1:c.-8T>G
- NM_001407907.1:c.-8T>G
- NM_001407908.1:c.-8T>G
- NM_001407909.1:c.-8T>G
- NM_001407910.1:c.-8T>G
- NM_001407915.1:c.-8T>G
- NM_001407916.1:c.-8T>G
- NM_001407917.1:c.-8T>G
- NM_001407918.1:c.-8T>G
- NM_001407919.1:c.181T>G
- NM_001407920.1:c.40T>G
- NM_001407921.1:c.40T>G
- NM_001407922.1:c.40T>G
- NM_001407923.1:c.40T>G
- NM_001407924.1:c.40T>G
- NM_001407925.1:c.40T>G
- NM_001407926.1:c.40T>G
- NM_001407927.1:c.40T>G
- NM_001407928.1:c.40T>G
- NM_001407929.1:c.40T>G
- NM_001407930.1:c.40T>G
- NM_001407931.1:c.40T>G
- NM_001407932.1:c.40T>G
- NM_001407933.1:c.40T>G
- NM_001407934.1:c.40T>G
- NM_001407935.1:c.40T>G
- NM_001407936.1:c.40T>G
- NM_001407937.1:c.181T>G
- NM_001407938.1:c.181T>G
- NM_001407939.1:c.181T>G
- NM_001407940.1:c.181T>G
- NM_001407941.1:c.181T>G
- NM_001407942.1:c.40T>G
- NM_001407943.1:c.40T>G
- NM_001407944.1:c.40T>G
- NM_001407945.1:c.40T>G
- NM_001407946.1:c.-8T>G
- NM_001407947.1:c.-8T>G
- NM_001407948.1:c.-8T>G
- NM_001407949.1:c.-8T>G
- NM_001407950.1:c.-8T>G
- NM_001407951.1:c.-8T>G
- NM_001407952.1:c.-8T>G
- NM_001407953.1:c.-8T>G
- NM_001407954.1:c.-8T>G
- NM_001407955.1:c.-8T>G
- NM_001407956.1:c.-8T>G
- NM_001407957.1:c.-8T>G
- NM_001407958.1:c.-8T>G
- NM_001407964.1:c.40T>G
- NM_001407968.1:c.181T>G
- NM_001407969.1:c.181T>G
- NM_001407970.1:c.181T>G
- NM_001407971.1:c.181T>G
- NM_001407972.1:c.181T>G
- NM_001407973.1:c.181T>G
- NM_001407974.1:c.181T>G
- NM_001407975.1:c.181T>G
- NM_001407976.1:c.181T>G
- NM_001407977.1:c.181T>G
- NM_001407978.1:c.181T>G
- NM_001407979.1:c.181T>G
- NM_001407980.1:c.181T>G
- NM_001407981.1:c.181T>G
- NM_001407982.1:c.181T>G
- NM_001407983.1:c.181T>G
- NM_001407984.1:c.181T>G
- NM_001407985.1:c.181T>G
- NM_001407986.1:c.181T>G
- NM_001407990.1:c.181T>G
- NM_001407991.1:c.181T>G
- NM_001407992.1:c.181T>G
- NM_001407993.1:c.181T>G
- NM_001408392.1:c.181T>G
- NM_001408396.1:c.181T>G
- NM_001408397.1:c.181T>G
- NM_001408398.1:c.181T>G
- NM_001408399.1:c.181T>G
- NM_001408400.1:c.181T>G
- NM_001408401.1:c.181T>G
- NM_001408402.1:c.181T>G
- NM_001408403.1:c.181T>G
- NM_001408404.1:c.181T>G
- NM_001408406.1:c.181T>G
- NM_001408407.1:c.181T>G
- NM_001408408.1:c.181T>G
- NM_001408410.1:c.40T>G
- NM_001408418.1:c.181T>G
- NM_001408419.1:c.181T>G
- NM_001408420.1:c.181T>G
- NM_001408421.1:c.181T>G
- NM_001408422.1:c.181T>G
- NM_001408423.1:c.181T>G
- NM_001408424.1:c.181T>G
- NM_001408425.1:c.181T>G
- NM_001408426.1:c.181T>G
- NM_001408427.1:c.181T>G
- NM_001408428.1:c.181T>G
- NM_001408429.1:c.181T>G
- NM_001408430.1:c.181T>G
- NM_001408431.1:c.181T>G
- NM_001408432.1:c.181T>G
- NM_001408433.1:c.181T>G
- NM_001408434.1:c.181T>G
- NM_001408435.1:c.181T>G
- NM_001408436.1:c.181T>G
- NM_001408437.1:c.181T>G
- NM_001408438.1:c.181T>G
- NM_001408439.1:c.181T>G
- NM_001408440.1:c.181T>G
- NM_001408441.1:c.181T>G
- NM_001408442.1:c.181T>G
- NM_001408443.1:c.181T>G
- NM_001408444.1:c.181T>G
- NM_001408445.1:c.181T>G
- NM_001408446.1:c.181T>G
- NM_001408447.1:c.181T>G
- NM_001408448.1:c.181T>G
- NM_001408450.1:c.181T>G
- NM_001408452.1:c.40T>G
- NM_001408453.1:c.40T>G
- NM_001408454.1:c.40T>G
- NM_001408455.1:c.40T>G
- NM_001408456.1:c.40T>G
- NM_001408457.1:c.40T>G
- NM_001408458.1:c.40T>G
- NM_001408459.1:c.40T>G
- NM_001408460.1:c.40T>G
- NM_001408461.1:c.40T>G
- NM_001408462.1:c.40T>G
- NM_001408463.1:c.40T>G
- NM_001408464.1:c.40T>G
- NM_001408465.1:c.40T>G
- NM_001408466.1:c.40T>G
- NM_001408467.1:c.40T>G
- NM_001408468.1:c.40T>G
- NM_001408469.1:c.40T>G
- NM_001408470.1:c.40T>G
- NM_001408472.1:c.181T>G
- NM_001408473.1:c.181T>G
- NM_001408478.1:c.-8T>G
- NM_001408479.1:c.-8T>G
- NM_001408480.1:c.-8T>G
- NM_001408481.1:c.-8T>G
- NM_001408482.1:c.-8T>G
- NM_001408483.1:c.-8T>G
- NM_001408484.1:c.-8T>G
- NM_001408485.1:c.-8T>G
- NM_001408489.1:c.-8T>G
- NM_001408490.1:c.-8T>G
- NM_001408491.1:c.-8T>G
- NM_001408492.1:c.-8T>G
- NM_001408493.1:c.-8T>G
- NM_001408494.1:c.181T>G
- NM_001408495.1:c.181T>G
- NM_001408496.1:c.40T>G
- NM_001408497.1:c.40T>G
- NM_001408498.1:c.40T>G
- NM_001408499.1:c.40T>G
- NM_001408500.1:c.40T>G
- NM_001408501.1:c.40T>G
- NM_001408502.1:c.-8T>G
- NM_001408503.1:c.40T>G
- NM_001408504.1:c.40T>G
- NM_001408505.1:c.40T>G
- NM_001408506.1:c.-8T>G
- NM_001408507.1:c.-8T>G
- NM_001408508.1:c.-8T>G
- NM_001408509.1:c.-8T>G
- NM_001408511.1:c.40T>G
- NM_001408513.1:c.-8T>G
- NM_001408514.1:c.-8T>G
- NM_007294.4:c.181T>GMANE SELECT
- NM_007297.4:c.40T>G
- NM_007298.4:c.181T>G
- NM_007299.4:c.181T>G
- NM_007300.4:c.181T>G
- NM_007304.2:c.181T>G
- NP_001394510.1:p.Cys61Gly
- NP_001394511.1:p.Cys61Gly
- NP_001394512.1:p.Cys61Gly
- NP_001394514.1:p.Cys61Gly
- NP_001394516.1:p.Cys61Gly
- NP_001394519.1:p.Cys61Gly
- NP_001394520.1:p.Cys61Gly
- NP_001394522.1:p.Cys61Gly
- NP_001394523.1:p.Cys61Gly
- NP_001394525.1:p.Cys61Gly
- NP_001394526.1:p.Cys61Gly
- NP_001394527.1:p.Cys61Gly
- NP_001394531.1:p.Cys61Gly
- NP_001394532.1:p.Cys61Gly
- NP_001394534.1:p.Cys61Gly
- NP_001394539.1:p.Cys61Gly
- NP_001394540.1:p.Cys61Gly
- NP_001394541.1:p.Cys61Gly
- NP_001394542.1:p.Cys61Gly
- NP_001394543.1:p.Cys61Gly
- NP_001394544.1:p.Cys61Gly
- NP_001394545.1:p.Cys61Gly
- NP_001394546.1:p.Cys61Gly
- NP_001394547.1:p.Cys61Gly
- NP_001394548.1:p.Cys61Gly
- NP_001394549.1:p.Cys61Gly
- NP_001394550.1:p.Cys61Gly
- NP_001394551.1:p.Cys61Gly
- NP_001394552.1:p.Cys61Gly
- NP_001394553.1:p.Cys61Gly
- NP_001394554.1:p.Cys61Gly
- NP_001394555.1:p.Cys61Gly
- NP_001394556.1:p.Cys61Gly
- NP_001394557.1:p.Cys61Gly
- NP_001394558.1:p.Cys61Gly
- NP_001394559.1:p.Cys61Gly
- NP_001394560.1:p.Cys61Gly
- NP_001394561.1:p.Cys61Gly
- NP_001394562.1:p.Cys61Gly
- NP_001394563.1:p.Cys61Gly
- NP_001394564.1:p.Cys61Gly
- NP_001394565.1:p.Cys61Gly
- NP_001394566.1:p.Cys61Gly
- NP_001394567.1:p.Cys61Gly
- NP_001394568.1:p.Cys61Gly
- NP_001394569.1:p.Cys61Gly
- NP_001394570.1:p.Cys61Gly
- NP_001394571.1:p.Cys61Gly
- NP_001394573.1:p.Cys61Gly
- NP_001394574.1:p.Cys61Gly
- NP_001394575.1:p.Cys61Gly
- NP_001394576.1:p.Cys61Gly
- NP_001394577.1:p.Cys61Gly
- NP_001394578.1:p.Cys61Gly
- NP_001394581.1:p.Cys61Gly
- NP_001394593.1:p.Cys61Gly
- NP_001394594.1:p.Cys61Gly
- NP_001394595.1:p.Cys61Gly
- NP_001394596.1:p.Cys61Gly
- NP_001394597.1:p.Cys61Gly
- NP_001394598.1:p.Cys61Gly
- NP_001394599.1:p.Cys61Gly
- NP_001394600.1:p.Cys61Gly
- NP_001394601.1:p.Cys61Gly
- NP_001394602.1:p.Cys61Gly
- NP_001394603.1:p.Cys61Gly
- NP_001394604.1:p.Cys61Gly
- NP_001394605.1:p.Cys61Gly
- NP_001394606.1:p.Cys61Gly
- NP_001394607.1:p.Cys61Gly
- NP_001394608.1:p.Cys61Gly
- NP_001394609.1:p.Cys61Gly
- NP_001394610.1:p.Cys61Gly
- NP_001394611.1:p.Cys61Gly
- NP_001394612.1:p.Cys61Gly
- NP_001394613.1:p.Cys61Gly
- NP_001394614.1:p.Cys61Gly
- NP_001394615.1:p.Cys61Gly
- NP_001394616.1:p.Cys61Gly
- NP_001394617.1:p.Cys61Gly
- NP_001394618.1:p.Cys61Gly
- NP_001394619.1:p.Cys61Gly
- NP_001394620.1:p.Cys61Gly
- NP_001394621.1:p.Cys14Gly
- NP_001394623.1:p.Cys14Gly
- NP_001394624.1:p.Cys14Gly
- NP_001394625.1:p.Cys14Gly
- NP_001394626.1:p.Cys14Gly
- NP_001394627.1:p.Cys14Gly
- NP_001394653.1:p.Cys14Gly
- NP_001394654.1:p.Cys14Gly
- NP_001394655.1:p.Cys14Gly
- NP_001394656.1:p.Cys14Gly
- NP_001394657.1:p.Cys14Gly
- NP_001394658.1:p.Cys14Gly
- NP_001394659.1:p.Cys14Gly
- NP_001394660.1:p.Cys14Gly
- NP_001394661.1:p.Cys14Gly
- NP_001394662.1:p.Cys14Gly
- NP_001394663.1:p.Cys14Gly
- NP_001394664.1:p.Cys14Gly
- NP_001394665.1:p.Cys14Gly
- NP_001394666.1:p.Cys14Gly
- NP_001394667.1:p.Cys14Gly
- NP_001394668.1:p.Cys14Gly
- NP_001394669.1:p.Cys14Gly
- NP_001394670.1:p.Cys14Gly
- NP_001394671.1:p.Cys14Gly
- NP_001394672.1:p.Cys14Gly
- NP_001394673.1:p.Cys14Gly
- NP_001394674.1:p.Cys14Gly
- NP_001394675.1:p.Cys14Gly
- NP_001394676.1:p.Cys14Gly
- NP_001394677.1:p.Cys14Gly
- NP_001394678.1:p.Cys14Gly
- NP_001394679.1:p.Cys14Gly
- NP_001394680.1:p.Cys14Gly
- NP_001394681.1:p.Cys14Gly
- NP_001394767.1:p.Cys14Gly
- NP_001394768.1:p.Cys14Gly
- NP_001394770.1:p.Cys14Gly
- NP_001394771.1:p.Cys14Gly
- NP_001394772.1:p.Cys14Gly
- NP_001394773.1:p.Cys14Gly
- NP_001394774.1:p.Cys14Gly
- NP_001394775.1:p.Cys14Gly
- NP_001394776.1:p.Cys14Gly
- NP_001394777.1:p.Cys14Gly
- NP_001394778.1:p.Cys14Gly
- NP_001394779.1:p.Cys14Gly
- NP_001394780.1:p.Cys14Gly
- NP_001394781.1:p.Cys14Gly
- NP_001394783.1:p.Cys61Gly
- NP_001394787.1:p.Cys61Gly
- NP_001394788.1:p.Cys61Gly
- NP_001394789.1:p.Cys61Gly
- NP_001394790.1:p.Cys61Gly
- NP_001394792.1:p.Cys61Gly
- NP_001394848.1:p.Cys61Gly
- NP_001394849.1:p.Cys14Gly
- NP_001394850.1:p.Cys14Gly
- NP_001394851.1:p.Cys14Gly
- NP_001394852.1:p.Cys14Gly
- NP_001394853.1:p.Cys14Gly
- NP_001394854.1:p.Cys14Gly
- NP_001394855.1:p.Cys14Gly
- NP_001394856.1:p.Cys14Gly
- NP_001394857.1:p.Cys14Gly
- NP_001394858.1:p.Cys14Gly
- NP_001394859.1:p.Cys14Gly
- NP_001394860.1:p.Cys14Gly
- NP_001394861.1:p.Cys14Gly
- NP_001394862.1:p.Cys14Gly
- NP_001394863.1:p.Cys14Gly
- NP_001394864.1:p.Cys14Gly
- NP_001394865.1:p.Cys14Gly
- NP_001394866.1:p.Cys61Gly
- NP_001394867.1:p.Cys61Gly
- NP_001394868.1:p.Cys61Gly
- NP_001394869.1:p.Cys61Gly
- NP_001394870.1:p.Cys61Gly
- NP_001394871.1:p.Cys14Gly
- NP_001394872.1:p.Cys14Gly
- NP_001394873.1:p.Cys14Gly
- NP_001394874.1:p.Cys14Gly
- NP_001394893.1:p.Cys14Gly
- NP_001394897.1:p.Cys61Gly
- NP_001394898.1:p.Cys61Gly
- NP_001394899.1:p.Cys61Gly
- NP_001394900.1:p.Cys61Gly
- NP_001394901.1:p.Cys61Gly
- NP_001394902.1:p.Cys61Gly
- NP_001394903.1:p.Cys61Gly
- NP_001394904.1:p.Cys61Gly
- NP_001394905.1:p.Cys61Gly
- NP_001394906.1:p.Cys61Gly
- NP_001394907.1:p.Cys61Gly
- NP_001394908.1:p.Cys61Gly
- NP_001394909.1:p.Cys61Gly
- NP_001394910.1:p.Cys61Gly
- NP_001394911.1:p.Cys61Gly
- NP_001394912.1:p.Cys61Gly
- NP_001394913.1:p.Cys61Gly
- NP_001394914.1:p.Cys61Gly
- NP_001394915.1:p.Cys61Gly
- NP_001394919.1:p.Cys61Gly
- NP_001394920.1:p.Cys61Gly
- NP_001394921.1:p.Cys61Gly
- NP_001394922.1:p.Cys61Gly
- NP_001395321.1:p.Cys61Gly
- NP_001395325.1:p.Cys61Gly
- NP_001395326.1:p.Cys61Gly
- NP_001395327.1:p.Cys61Gly
- NP_001395328.1:p.Cys61Gly
- NP_001395329.1:p.Cys61Gly
- NP_001395330.1:p.Cys61Gly
- NP_001395331.1:p.Cys61Gly
- NP_001395332.1:p.Cys61Gly
- NP_001395333.1:p.Cys61Gly
- NP_001395335.1:p.Cys61Gly
- NP_001395336.1:p.Cys61Gly
- NP_001395337.1:p.Cys61Gly
- NP_001395339.1:p.Cys14Gly
- NP_001395347.1:p.Cys61Gly
- NP_001395348.1:p.Cys61Gly
- NP_001395349.1:p.Cys61Gly
- NP_001395350.1:p.Cys61Gly
- NP_001395351.1:p.Cys61Gly
- NP_001395352.1:p.Cys61Gly
- NP_001395353.1:p.Cys61Gly
- NP_001395354.1:p.Cys61Gly
- NP_001395355.1:p.Cys61Gly
- NP_001395356.1:p.Cys61Gly
- NP_001395357.1:p.Cys61Gly
- NP_001395358.1:p.Cys61Gly
- NP_001395359.1:p.Cys61Gly
- NP_001395360.1:p.Cys61Gly
- NP_001395361.1:p.Cys61Gly
- NP_001395362.1:p.Cys61Gly
- NP_001395363.1:p.Cys61Gly
- NP_001395364.1:p.Cys61Gly
- NP_001395365.1:p.Cys61Gly
- NP_001395366.1:p.Cys61Gly
- NP_001395367.1:p.Cys61Gly
- NP_001395368.1:p.Cys61Gly
- NP_001395369.1:p.Cys61Gly
- NP_001395370.1:p.Cys61Gly
- NP_001395371.1:p.Cys61Gly
- NP_001395372.1:p.Cys61Gly
- NP_001395373.1:p.Cys61Gly
- NP_001395374.1:p.Cys61Gly
- NP_001395375.1:p.Cys61Gly
- NP_001395376.1:p.Cys61Gly
- NP_001395377.1:p.Cys61Gly
- NP_001395379.1:p.Cys61Gly
- NP_001395381.1:p.Cys14Gly
- NP_001395382.1:p.Cys14Gly
- NP_001395383.1:p.Cys14Gly
- NP_001395384.1:p.Cys14Gly
- NP_001395385.1:p.Cys14Gly
- NP_001395386.1:p.Cys14Gly
- NP_001395387.1:p.Cys14Gly
- NP_001395388.1:p.Cys14Gly
- NP_001395389.1:p.Cys14Gly
- NP_001395390.1:p.Cys14Gly
- NP_001395391.1:p.Cys14Gly
- NP_001395392.1:p.Cys14Gly
- NP_001395393.1:p.Cys14Gly
- NP_001395394.1:p.Cys14Gly
- NP_001395395.1:p.Cys14Gly
- NP_001395396.1:p.Cys14Gly
- NP_001395397.1:p.Cys14Gly
- NP_001395398.1:p.Cys14Gly
- NP_001395399.1:p.Cys14Gly
- NP_001395401.1:p.Cys61Gly
- NP_001395402.1:p.Cys61Gly
- NP_001395423.1:p.Cys61Gly
- NP_001395424.1:p.Cys61Gly
- NP_001395425.1:p.Cys14Gly
- NP_001395426.1:p.Cys14Gly
- NP_001395427.1:p.Cys14Gly
- NP_001395428.1:p.Cys14Gly
- NP_001395429.1:p.Cys14Gly
- NP_001395430.1:p.Cys14Gly
- NP_001395432.1:p.Cys14Gly
- NP_001395433.1:p.Cys14Gly
- NP_001395434.1:p.Cys14Gly
- NP_001395440.1:p.Cys14Gly
- NP_009225.1:p.Cys61Gly
- NP_009225.1:p.Cys61Gly
- NP_009228.2:p.Cys14Gly
- NP_009229.2:p.Cys61Gly
- NP_009229.2:p.Cys61Gly
- NP_009230.2:p.Cys61Gly
- NP_009231.2:p.Cys61Gly
- NP_009235.2:p.Cys61Gly
- LRG_292t1:c.181T>G
- LRG_292:g.111497T>G
- LRG_292p1:p.Cys61Gly
- NC_000017.10:g.41258504A>C
- NM_007294.3:c.181T>G
- NM_007298.3:c.181T>G
- NM_007299.3:c.181T>G
- NM_007300.3:c.181T>G
- NR_027676.2:n.383T>G
- P38398:p.Cys61Gly
- U14680.1:n.300T>G
- p.C61G
This HGVS expression did not pass validation- Nucleotide change:
- 300T>G
- Protein change:
- C14G; CYS61GLY
- Links:
- BRCA1-HCI: BRCA1_00099; UniProtKB: P38398#VAR_007757; OMIM: 113705.0002; dbSNP: rs28897672
- NCBI 1000 Genomes Browser:
- rs28897672
- Molecular consequence:
- NM_001407581.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407582.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407583.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407585.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407587.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407590.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407591.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407593.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407594.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407596.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407597.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407598.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407602.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407603.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407605.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407610.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407611.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407612.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407613.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407614.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407615.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407616.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407617.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407618.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407619.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407620.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407621.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407622.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407623.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407624.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407625.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407626.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407627.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407628.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407629.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407630.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407631.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407632.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407633.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407634.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407635.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407636.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407637.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407638.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407639.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407640.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407641.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407642.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407644.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407645.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407646.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407647.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407648.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407649.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407652.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407664.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407665.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407666.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407667.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407668.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407669.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407670.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407671.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407672.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407673.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407674.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407675.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407676.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407677.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407678.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407679.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407680.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407681.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407682.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407683.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407684.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407685.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407686.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407687.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407688.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407689.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407690.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407691.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407692.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407694.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407695.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407696.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407697.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407698.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407724.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407725.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407726.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407727.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407728.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407729.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407730.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407731.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407732.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407733.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407734.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407735.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407736.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407737.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407738.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407739.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407740.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407741.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407742.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407743.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407744.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407745.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407746.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407747.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407748.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407749.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407750.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407751.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407752.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407838.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407839.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407841.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407842.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407843.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407844.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407845.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407846.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407847.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407848.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407849.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407850.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407851.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407852.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407854.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407858.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407859.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407860.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407861.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407863.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407919.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407920.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407921.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407922.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407923.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407924.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407925.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407926.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407927.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407928.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407929.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407930.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407931.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407932.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407933.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407934.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407935.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407936.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407937.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407938.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407939.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407940.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407941.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407942.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407943.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407944.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407945.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407964.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407968.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407969.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407970.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407971.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407972.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407973.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407974.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407975.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407976.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407977.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407978.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407979.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407980.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407981.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407982.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407983.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407984.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407985.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407986.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407990.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407991.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407992.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001407993.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408392.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408396.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408397.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408398.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408399.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408400.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408401.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408402.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408403.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408404.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408406.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408407.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408408.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408410.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408418.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408419.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408420.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408421.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408422.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408423.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408424.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408425.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408426.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408427.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408428.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408429.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408430.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408431.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408432.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408433.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408434.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408435.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408436.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408437.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408438.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408439.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408440.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408441.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408442.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408443.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408444.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408445.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408446.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408447.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408448.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408450.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408452.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408453.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408454.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408455.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408456.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408457.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408458.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408459.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408460.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408461.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408462.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408463.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408464.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408465.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408466.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408467.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408468.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408469.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408470.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408472.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408473.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408494.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408495.1:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408496.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408497.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408498.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408499.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408500.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408501.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408503.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408504.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408505.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_001408511.1:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_007294.4:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_007297.4:c.40T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_007298.4:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_007299.4:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_007300.4:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NM_007304.2:c.181T>G - missense variant - [Sequence Ontology: SO:0001583]
- NR_027676.2:n.383T>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
- Functional consequence:
- functionally_abnormal [Sequence Ontology: SO:0002218] - Comment(s)
- The saturation genome editing (SGE) assay for BRCA1 NM_007294.3:c.181T>G, a MISSENSE variant, produced a function score of -1.74, corresponding to a functional classification of LOSS_OF_FUNCTION. SGE function score ranges for classification are as follows: ‘functional’, score > -0.748; ‘intermediate’, -0.748 > score > -1.328; ‘non-functional’, score < -1.328. The median synonymous SNV scored 0.0 and the median nonsense SNV scored -2.12.
- variation affecting protein function [Variation Ontology: 0003]
- functionally_abnormal [Sequence Ontology: SO:0002218] - Comment(s)
- Observations:
- 886
Condition(s)
Assertion and evidence details
Submission Accession | Submitter | Review Status (Assertion method) | Clinical Significance (Last evaluated) | Origin | Method | Citations |
---|---|---|---|---|---|---|
SCV000039517 | OMIM | no assertion criteria provided | Pathogenic (Jun 1, 2000) | unknown | literature only | |
SCV000109295 | Sharing Clinical Reports Project (SCRP) | no assertion criteria provided | Pathogenic (Sep 18, 2013) | germline | clinical testing | |
SCV000144574 | Breast Cancer Information Core (BIC) (BRCA1) | no classification provided | not provided | germline, somatic, unknown | clinical testing | PubMed (2) Johannsson et al AJHG 58:441-450, 1997, |
SCV000195877 | Michigan Medical Genetics Laboratories, University of Michigan | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (Nov 3, 2014) | germline | clinical testing | |
SCV000244308 | Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) | reviewed by expert panel (ENIGMA BRCA1/2 Classification Criteria (2015)) | Pathogenic (Aug 10, 2015) | germline | curation | PubMed (1) ENIGMA BRCA1/2 Classification Criteria (2015), |
SCV000325150 | Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge | criteria provided, single submitter (CIMBA Mutation Classification guidelines May 2016) | Pathogenic (Oct 2, 2015) | germline | clinical testing | CIMBA_Mutation_Classification_guidelines_May16.pdf, |
SCV000564349 | Department of Medical Genetics, Oslo University Hospital | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (Jul 1, 2015) | germline | clinical testing | |
SCV000591246 | Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)
| no assertion criteria provided | Pathogenic | unknown | clinical testing | |
SCV000677634 | Counsyl | criteria provided, single submitter (Counsyl Autosomal Dominant Disease Classification criteria (2015)) | Pathogenic (Nov 12, 2015) | unknown | clinical testing | |
SCV000733679 | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen - VKGL Data-share Consensus | no assertion criteria provided | Pathogenic | germline | clinical testing | |
SCV000839890 | Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (May 25, 2017) | germline | clinical testing | |
SCV001140644 | Mendelics | criteria provided, single submitter (Mendelics Assertion Criteria 2017) | Pathogenic (May 28, 2019) | unknown | clinical testing | |
SCV001242516 | Brotman Baty Institute, University of Washington | no classification provided | not provided | not applicable | in vitro | |
SCV001251421 | Institute of Human Genetics, University of Leipzig Medical Center | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (Jun 11, 2024) | unknown | clinical testing | |
SCV001430694 | Institute of Genomics, University of Tartu | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic | germline | research | |
SCV001499631 | Department of Molecular Diagnostics, Institute of Oncology Ljubljana | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (Apr 2, 2020) | germline | clinical testing | |
SCV002070498 | Genetic Services Laboratory, University of Chicago | no assertion criteria provided | Pathogenic (Feb 5, 2021) | germline | clinical testing | |
SCV002104282 | University of Science and Technology Houari Boumediene, Laboratory of Molecular and Cellular Biology (LBCM) | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic | germline | clinical testing | |
SCV002580059 | MGZ Medical Genetics Center | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (May 13, 2022) | germline | clinical testing | |
SCV002589065 | BRCAlab, Lund University | no assertion criteria provided | Pathogenic (Aug 26, 2022) | germline | clinical testing | |
SCV002762793 | Centre for Mendelian Genomics, University Medical Centre Ljubljana | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (Dec 9, 2022) | germline | research | |
SCV004100885 | Medical Genetics, Medical University Pleven | no assertion criteria provided | Pathogenic | germline | research | |
SCV004212709 | Baylor Genetics | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (Mar 21, 2024) | unknown | clinical testing | |
SCV004823691 | All of Us Research Program, National Institutes of Health | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (Jan 6, 2024) | germline | clinical testing | |
SCV005045920 | Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet | criteria provided, single submitter (ACMG Guidelines, 2015) | Pathogenic (May 27, 2024) | germline | clinical testing |
Summary from all submissions
Ethnicity | Origin | Affected | Individuals | Families | Chromosomes tested | Number Tested | Family history | Method |
---|---|---|---|---|---|---|---|---|
not provided | germline | yes | 110 | 11 | not provided | not provided | not provided | clinical testing, research |
not provided | germline | no | not provided | not provided | not provided | not provided | not provided | research |
not provided | germline | not provided | 67 | not provided | not provided | 67 | not provided | clinical testing |
not provided | germline | unknown | 10 | 875 | not provided | 108544 | not provided | clinical testing, research, curation |
not provided | not applicable | not applicable | not provided | not provided | not provided | not provided | not provided | in vitro |
not provided | not provided | yes | 2 | not provided | not provided | not provided | not provided | clinical testing |
not provided | somatic | yes | 1 | not provided | not provided | not provided | not provided | clinical testing |
not provided | unknown | yes | 13 | not provided | not provided | not provided | not provided | clinical testing |
not provided | unknown | not provided | not provided | not provided | not provided | not provided | not provided | literature only |
not provided | unknown | unknown | not provided | not provided | not provided | not provided | not provided | clinical testing |
Ashkenazi | germline | yes | 1 | not provided | not provided | not provided | not provided | clinical testing |
Austrian | germline | yes | 10 | not provided | not provided | not provided | not provided | clinical testing |
Caucasian | germline | yes | 41 | not provided | not provided | not provided | not provided | clinical testing |
Caucasian | not provided | yes | 3 | not provided | not provided | not provided | not provided | clinical testing |
Caucasian Non Hispanic | germline | yes | 4 | not provided | not provided | not provided | not provided | clinical testing |
Central/Eastern European | germline | yes | 21 | not provided | not provided | not provided | not provided | clinical testing |
Czech | germline | yes | 1 | not provided | not provided | not provided | not provided | clinical testing |
German, Uruguayan | germline | yes | 1 | not provided | not provided | not provided | not provided | clinical testing |
Latvian | germline | yes | 1 | not provided | not provided | not provided | not provided | clinical testing |
Native American | germline | yes | 1 | not provided | not provided | not provided | not provided | clinical testing |
Western European | germline | yes | 52 | not provided | not provided | not provided | not provided | clinical testing |
Western European, Ashkenazi | germline | yes | 1 | not provided | not provided | not provided | not provided | clinical testing |
Western European, Central/Eastern European | germline | yes | 4 | not provided | not provided | not provided | not provided | clinical testing |
Western European, Swedish, Englishranian, Norwegian, Belgian | germline | yes | 1 | not provided | not provided | not provided | not provided | clinical testing |
Western Europeanan, Central/Eastern European | germline | yes | 5 | not provided | not provided | not provided | not provided | clinical testing |
Western, Central/Eastern European | germline | yes | 3 | not provided | not provided | not provided | not provided | clinical testing |
Citations
PubMed
Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.
Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS.
Nat Genet. 1995 Apr;9(4):439-43.
- PMID:
- 7795652
Foretova L, Machackova E, Navratilova M, Pavlu H, Hruba M, Lukesova M, Valik D.
Hum Mutat. 2004 Apr;23(4):397-8.
- PMID:
- 15024741
Details of each submission
From OMIM, SCV000039517.3
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | literature only | PubMed (2) |
Description
Gorski et al. (2000) identified a cys61-to-gly (C61G) mutation in the BRCA1 gene to be a founder mutation in Polish families with breast-ovarian cancer (604370), accounting for 20% of identified mutations. They studied 66 families in which at least 3 related females were affected with breast or ovarian cancer and at least 1 of these 3 had been diagnosed with cancer before the age of 50. Mutations were identified in 35 (53%) of the 66 families.
Merajver et al. (1995) analyzed genomic DNA of tumor and normal fractions of 47 ovarian cancers for mutations in BRCA1 using the SSCP technique. Somatic mutations in the BRCA1 gene were identified in 4 tumors, all of which also had loss of heterozygosity at a BRCA1 intragenic marker. One of these, found in an endometrioid ovarian carcinoma in a 53-year-old woman, was a C61G substitution in the zinc finger motif. The data supported a tumor-suppressor mechanism for BRCA1.
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | unknown | not provided | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Sharing Clinical Reports Project (SCRP), SCV000109295.5
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | not provided |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | not provided | 67 | not provided | not provided | not provided | not provided | not provided | See 1 |
Co-occurrences
# | Zygosity | Alleles | Number of Observations |
---|---|---|---|
1 | SingleHeterozygote | BRCA2:9875T>C (L3216P) | 1 |
1 | SingleHeterozygote | BRCA2:2510A>C (Y761S) | 1 |
From Breast Cancer Information Core (BIC) (BRCA1), SCV000144574.2
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | 78 | not provided | not provided | clinical testing | PubMed (2) |
2 | not provided | 6 | not provided | not provided | clinical testing | PubMed (2) |
3 | not provided | 1 | not provided | not provided | clinical testing | PubMed (2) |
4 | not provided | 4 | not provided | not provided | clinical testing | PubMed (2) |
5 | not provided | 2 | not provided | not provided | clinical testing | PubMed (2) |
6 | not provided | 1 | not provided | not provided | clinical testing | PubMed (2) |
7 | not provided | 1 | not provided | not provided | clinical testing | PubMed (2) |
8 | not provided | 1 | not provided | not provided | clinical testing | PubMed (2) |
9 | not provided | 5 | not provided | not provided | clinical testing | PubMed (2) |
10 | not provided | 1 | not provided | not provided | clinical testing | PubMed (2) |
11 | not provided | 2 | not provided | not provided | clinical testing | PubMed (2) |
12 | Ashkenazi | 1 | not provided | not provided | clinical testing | PubMed (2) |
13 | Austrian | 10 | not provided | not provided | clinical testing | PubMed (2) |
14 | Caucasian | 2 | not provided | not provided | clinical testing | PubMed (2) |
15 | Caucasian | 1 | not provided | not provided | clinical testing | PubMed (2) |
16 | Caucasian | 2 | not provided | not provided | clinical testing | PubMed (2) |
17 | Caucasian | 18 | not provided | not provided | clinical testing | PubMed (2) |
18 | Caucasian | 1 | not provided | not provided | clinical testing | PubMed (2) |
19 | Caucasian | 12 | not provided | not provided | clinical testing | PubMed (2) |
20 | Caucasian | 4 | not provided | not provided | clinical testing | PubMed (2) |
21 | Caucasian | 1 | not provided | not provided | clinical testing | PubMed (2) |
22 | Caucasian | 1 | not provided | not provided | clinical testing | PubMed (2) |
23 | Caucasian | 2 | not provided | not provided | clinical testing | PubMed (2) |
24 | Caucasian Non Hispanic | 4 | not provided | not provided | clinical testing | PubMed (2) |
25 | Central/Eastern European | 21 | not provided | not provided | clinical testing | PubMed (2) |
26 | Czech | 1 | not provided | not provided | clinical testing | PubMed (2) |
27 | German, Uruguayan | 1 | not provided | not provided | clinical testing | PubMed (2) |
28 | Latvian | 1 | not provided | not provided | clinical testing | PubMed (2) |
29 | Native American | 1 | not provided | not provided | clinical testing | PubMed (2) |
30 | Western European | 52 | not provided | not provided | clinical testing | PubMed (2) |
31 | Western European, Ashkenazi | 1 | not provided | not provided | clinical testing | PubMed (2) |
32 | Western European, Central/Eastern European | 4 | not provided | not provided | clinical testing | PubMed (2) |
33 | Western European, Swedish, Englishranian, Norwegian, Belgian | 1 | not provided | not provided | clinical testing | PubMed (2) |
34 | Western Europeanan, Central/Eastern European | 5 | not provided | not provided | clinical testing | PubMed (2) |
35 | Western, Central/Eastern European | 3 | not provided | not provided | clinical testing | PubMed (2) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | 78 | not provided | not provided | not provided | |
2 | germline | yes | not provided | not provided | not provided | 6 | not provided | not provided | not provided | |
3 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
4 | germline | yes | not provided | not provided | not provided | 4 | not provided | not provided | not provided | |
5 | germline | yes | not provided | not provided | not provided | 2 | not provided | not provided | not provided | |
6 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
7 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
8 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
9 | germline | yes | not provided | not provided | not provided | 5 | not provided | not provided | not provided | |
10 | somatic | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
11 | unknown | yes | not provided | not provided | not provided | 2 | not provided | not provided | not provided | |
12 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
13 | germline | yes | not provided | not provided | not provided | 10 | not provided | not provided | not provided | |
14 | germline | yes | not provided | not provided | not provided | 2 | not provided | not provided | not provided | |
15 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
16 | germline | yes | not provided | not provided | not provided | 2 | not provided | not provided | not provided | |
17 | germline | yes | not provided | not provided | not provided | 18 | not provided | not provided | not provided | |
18 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
19 | germline | yes | not provided | not provided | not provided | 12 | not provided | not provided | not provided | |
20 | germline | yes | not provided | not provided | not provided | 4 | not provided | not provided | not provided | |
21 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
22 | unknown | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
23 | unknown | yes | not provided | not provided | not provided | 2 | not provided | not provided | not provided | |
24 | germline | yes | not provided | not provided | not provided | 4 | not provided | not provided | not provided | |
25 | germline | yes | not provided | not provided | not provided | 21 | not provided | not provided | not provided | |
26 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
27 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
28 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
29 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
30 | germline | yes | not provided | not provided | not provided | 52 | not provided | not provided | not provided | |
31 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
32 | germline | yes | not provided | not provided | not provided | 4 | not provided | not provided | not provided | |
33 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
34 | germline | yes | not provided | not provided | not provided | 5 | not provided | not provided | not provided | |
35 | germline | yes | not provided | not provided | not provided | 3 | not provided | not provided | not provided |
From Michigan Medical Genetics Laboratories, University of Michigan, SCV000195877.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (1) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | Blood | not provided | not provided | not provided | not provided | not provided |
From Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA), SCV000244308.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | curation | PubMed (1) |
Description
IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 5 based on posterior probability = 1
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | unknown | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge, SCV000325150.4
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | not provided |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | unknown | not provided | not provided | not provided | not provided | not provided | 875 | not provided |
From Department of Medical Genetics, Oslo University Hospital, SCV000564349.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | 5 | not provided | not provided | clinical testing | PubMed (1) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | 5 | not provided | not provided | not provided |
From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV000591246.2
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | 13 | not provided | not provided | clinical testing | not provided |
Description
The p.Cys61Gly variant has been identified in 64 out of 16070 proband chromosomes (frequency 0.004) in individuals with unilateral and contralateral breast cancers, ovarian cancers and familial breast and ovarian cancer phenotype, and also found in 4 out of 12088 control chromosomes (frequency <0.0001) included in these studies (Bergthorsson 2001, Brozek 2011, Bogdanova 2010, Capanu 2011, Elsakov 2010, Friedman 1994, Scott 2003, Uglanitsa 2010, Zhang 2011). It is listed in dbSNP database presented “with probable pathogenic allele” (ID#: rs28897672) however no frequency information was available. The p.Cys61 residue is highly conserved in mammals and other species; however, computational analyses (PolyPhen2, SIFT, AlignGVGD) provide inconsistent predictions regarding the impact to the protein and this information is not very predictive of pathogenicity. Functional studies have shown that this variant abolishes ubiquitin ligase activity of the BRCA1-BARD1 heterodimer and impairs BRCA1 DNA repair function, and therefore, it was considered as a pathogenic mutation (Au 2005, Brzovic 2003, Houvras 2000, Millot 2011, Morris 2004, Morris 2006, Ransburgh 2010, Ruffner 2001, Sweet 2010, Caliqo 2009, Humphrey 1997). In addition, this variant has been presented as a clinically important variant in the UMD (40 times) and the BIC (230 times) databases. In summary, based on the above information, this variant is classified as pathogenic.
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | unknown | yes | not provided | not provided | not provided | 13 | not provided | not provided | not provided |
From Counsyl, SCV000677634.2
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (8) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | unknown | unknown | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen - VKGL Data-share Consensus, SCV000733679.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | not provided |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine, SCV000839890.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (1) |
Description
The c.181T>G (p.Cys61Gly) variant has been detected in a multiple patients with breast and ovarian cancer [PMID 20507347, 21965345, 21503673, 20180014, 20345474, 23695190, 24728189, 21324516, 20569256 among others] and prostate cancer [PMID 27433846]. Functional in vitro assays showed that this variant was deleterious [PMID 23867111]. This variant has been reported in 8 non-Finnish Europeans from the ExAC database (http://exac.broadinstitute.org/variant/17-41258504-A-C). This variant occurs at high frequency in Eastern European countries and is considered a founder mutation in these countries [PMID 20507347, 20345474]. Cysteine at amino acid position 61 of the BRCA1 protein is highly conserved in mammals. While not validated for clinical use, computer-based algorithms predict this p.Cys61Gly change to be deleterious. Other changes affecting the same amino acid have been reported in patients with breast and/or ovarian cancer (p.Cys61Arg, p.Cys61Ser, p.Cys61Tyr). This variant is classified as pathogenic.
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | unknown | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Mendelics, SCV001140644.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | not provided |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | unknown | unknown | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Brotman Baty Institute, University of Washington, SCV001242516.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | in vitro | PubMed (1) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | not applicable | not applicable | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Institute of Human Genetics, University of Leipzig Medical Center, SCV001251421.6
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (1) |
Description
Criteria applied: PP1_VSTR,PVS1_RNA
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | unknown | yes | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Institute of Genomics, University of Tartu, SCV001430694.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | 1 | not provided | not provided | research | PubMed (1) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | unknown | not provided | not provided | not provided | 1 | not provided | not provided | not provided |
From Department of Molecular Diagnostics, Institute of Oncology Ljubljana, SCV001499631.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (1) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Genetic Services Laboratory, University of Chicago, SCV002070498.3
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | not provided |
Description
DNA sequence analysis of the BRCA1 gene demonstrated a sequence change, c.181T>G, in exon 4 that results in an amino acid change, p.Cys61Gly. This sequence change has been described in the gnomAD database with a low population frequency of 0.0032% (dbSNP rs28897672). The p.Cys61Gly change affects a highly conserved amino acid residue located in a domain of the BRCA1 protein that is known to be functional. The p.Cys61Gly substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This sequence change has been reported in a significant number of individuals with breast and ovarian cancer (PMID: 7894493, 10788334, 21324516, 20180014, 20345474, 20507347, 20569256, 19594371). Experimental studies have also demonstrated that this variant disrupts several aspects of BRCA1 function (PMID: 11278247, 9525870, 22172724, 23161852, 23867111). For these reasons, this variant has been classified as Pathogenic.
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From University of Science and Technology Houari Boumediene, Laboratory of Molecular and Cellular Biology (LBCM), SCV002104282.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | 1 | not provided | not provided | clinical testing | PubMed (2) | |
2 | not provided | not provided | not provided | clinical testing | PubMed (2) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | 1 | not provided | not provided | not provided | |
2 | germline | yes | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From MGZ Medical Genetics Center, SCV002580059.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | 5 | not provided | not provided | clinical testing | PubMed (1) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | 5 | not provided | not provided | not provided |
From BRCAlab, Lund University, SCV002589065.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | not provided |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | not provided | not provided | 11 | not provided |
From Centre for Mendelian Genomics, University Medical Centre Ljubljana, SCV002762793.2
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | research | PubMed (1) |
Description
PS3, PS4_STR, PM5_STR, PP1
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | no | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Medical Genetics, Medical University Pleven, SCV004100885.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | research | not provided |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From Baylor Genetics, SCV004212709.2
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (1) |
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | unknown | unknown | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
From All of Us Research Program, National Institutes of Health, SCV004823691.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | 9 | not provided | not provided | clinical testing | PubMed (20) |
Description
The c.181T>G (p.Cys61Gly) variant of BRCA1 has been detected in multiple individuals with breast and ovarian cancer (PMID: 7894493, 10447273, 10788334, 11102977, 19594371, 20180014, 20345474, 20507347, 20569256, 20180014, 21324516, 21503673, 21965345, 23695190, 24728189, 29492181) and prostate cancer (PMID: 27433846). Functional in vitro assays showed that this variant increases proteolytic susceptibility of the COOH-terminal portion of the NH2-terminal domain and perturbs the oligomerization properties of BRCA1 (PMID: 9525870), fails to reverse radiation hypersensitivity (PMID: 11320250), and damages ubiquitin ligase activity (PMID: 11278247). This variant has been reported in 7 non-Finnish Europeans from gnomAD. This variant occurs at high frequency in Eastern European countries and is considered a founder mutation in these countries (PMID: 20507347, 20345474). Cysteine at amino acid position 61 of the BRCA1 protein is highly conserved in mammals. While not validated for clinical use, computer-based algorithms predict this p.Cys61Gly change to be deleterious. Other changes affecting the same amino acid have been reported in individuals with breast and/or ovarian cancer (p.Cys61Arg, p.Cys61Ser, p.Cys61Tyr). This variant is classified as pathogenic.
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | unknown | 108544 | not provided | not provided | 9 | not provided | not provided | not provided |
From Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, SCV005045920.1
# | Ethnicity | Individuals | Chromosomes Tested | Family History | Method | Citations |
---|---|---|---|---|---|---|
1 | not provided | not provided | not provided | not provided | clinical testing | PubMed (1) |
Description
PP3; PS3; PP1_Strong; Expert panel
# | Sample | Method | Observation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences | |
1 | germline | yes | not provided | not provided | not provided | not provided | not provided | not provided | not provided |
Last Updated: Oct 13, 2024